The third dimension of reading the sugar code by lectins: Design of glycoclusters with cyclic scaffolds as tools with the Aim to Define Correlations between spatial presentation and activity

Molecules

Volumn 18, Issue 4, 2013, Pages 4026-4053

  Murphy, Paul V ^a   André, Sabine ^b   Gabius, Hans Joachim ^b  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Calixarene; Cyclodextrin; Galectin; Glycome; Glycopeptide; Glycophane

Indexed keywords

CALIXARENE; CYCLODEXTRIN; GALECTIN; GLYCOCONJUGATE; LACTOSE; LIGAND; OLIGOSACCHARIDE; POLYSACCHARIDE;

CHEMICAL STRUCTURE; CHEMISTRY; REVIEW;

CALIXARENES; CYCLODEXTRINS; GALECTINS; GLYCOCONJUGATES; LACTOSE; LIGANDS; MODELS, MOLECULAR; OLIGOSACCHARIDES; POLYSACCHARIDES;

EID: 84876782219     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules18044026     Document Type: Review

References (140)

1. Bond, A.E.; Row, P.E.; Dudley, E. Post-translation modification of proteins; Methodologies and applications in plant sciences. Phytochemistry 2011, 72, 975-996.
2. Hunter, T. Why nature chose phosphate to modify proteins. Phil. Trans. R. Soc. B 2012, 367, 2513-2516.
3. Reuter, G.; Gabius, H.-J. Eukaryotic glycosylation: whim of nature or multipurpose tool? Cell. Mol. Life Sci. 1999, 55, 368-422.
4. Spiro, R.G. Protein glycosylation: Nature, Distribution, Enzymatic formation, And disease implications of glycopeptide bonds. Glycobiology 2002, 12, 43R-56R.
5. Zuber, C.; Roth, J. N-Glycosylation. In The Sugar Code. Fundamentals of Glycosciences; Gabius, H.-J., Ed.; Wiley-VCH: Weinheim, Germany, 2009; pp. 87-110.
6. Patsos, G.; Corfield, A. O-Glycosylation: Structural diversity and function. In The Sugar Code. Fundamentals of Glycosciences; Gabius, H.-J., Ed.; Wiley-VCH: Weinheim, Germany, 2009; pp. 111-137.
7. Wilson, I.B.H.; Paschinger, H.; Rendic, D. Glycosylation of model and "lower" organisms. In The Sugar Code. Fundamentals of Glycosciences; Gabius, H.-J., Ed.; Wiley-VCH: Weinheim, Germany, 2009; pp. 139-154.
8. Buddecke, E. Proteoglycans. In The Sugar Code. Fundamentals of Glycosciences; Gabius, H.-J., Ed.; Wiley-VCH: Weinheim, Germany, 2009; pp. 199-216.
9. Moremen, K.W.; Tiemeyer, M.; Nairn, A.V. Vertebrate protein glycosylation: Diversity, Synthesis and function. Nat. Rev. Mol. Cell Biol. 2012, 13, 448-462.
10. Muthana, S.M.; Campbell, C.T.; Gildersleeve, J.C. Modifications of glycans: Biological significance and therapeutic opportunities. ACS Chem. Biol. 2012, 7, 31-43.
11. Vogt, G.; Chapgier, A.; Yang, K.; Chuzhanova, N.; Feinberg, J.; Fieschi, C.; Boisson-Dupuis, S.; Alcais, A.; Filipe-Santos, O.; Bustamante, J.; et al. Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations. Nat. Genet. 2005, 37, 692-700.
12. Vogt, G.; Vogt, B.; Chuzhanova, N.; Julenius, K.; Cooper, D.N.; Casanova, J.L. Gain-ofglycosylation mutations. Curr. Opin. Genet. Dev. 2007, 17, 245-251.
13. Hennet, T. Diseases of glycosylation. In The Sugar Code. Fundamentals of Glycosciences; Gabius, H.-J., Ed.; Wiley-VCH: Weinheim, Germany, 2009; pp. 365-383.
14. Honke, K.; Taniguchi, N. Animal models to delineate glycan functionality. In The Sugar Code. Fundamentals of Glycosciences; Gabius, H.-J., Ed.; Wiley-VCH: Weinheim, Germany, 2009; pp. 385-401.
15. Nakagawa, H. Analytical aspects: Analysis of protein-bound glycans. In The Sugar Code. Fundamentals of Glycosciences; Gabius, H.-J., Ed.; Wiley-VCH: Weinheim, Germany, 2009; pp. 71-83.
16. Higgins, E. Carbohydrate analysis throughout the development of a protein therapeutic. Glycoconj. J. 2010, 27, 211-225.
17. Hansen, S.F.; Bettler, E.; Rinnan, A.; Engelsen, S.B.; Breton, C. Exploring genomes for glycosyltransferases. Mol. BioSyst. 2010, 6, 1773-1781.
18. Gabius, H.-J.; André, S.; Kaltner, H.; Siebert, H.-C. The sugar code: Functional lectinomics. Biochim. Biophys. Acta 2002, 1572, 165-177.
19. Cummings, R.D. The repertoire of glycan determinants in the human glycome. Mol. BioSyst. 2009, 5, 1087-1104.
20. Ma, B.; Simala-Grant, J.L.; Taylor, D.E. Fucosylation in prokaryotes and eukaryotes. Glycobiology 2006, 16, 158R-184R.
21. Aplin, J.D.; Jones, C.J. Fucose, Placental evolution and the glycocode. Glycobiology 2012, 22, 470-478.
22. Harduin-Lepers, A.; Mollicone, R.; Delannoy, P.; Oriol, R. The animal sialyltransferases and sialyltransferase-related genes: A phylogenetic approach. Glycobiology 2005, 15, 805-817.
23. Takashima, S. Characterization of mouse sialyltransferase genes: Their evolution and diversity. Biosci. Biotechnol. Biochem. 2008, 72, 1155-1167.
24. Amano, M.; Eriksson, H.; Manning, J.C.; Detjen, K.M.; André, S.; Nishimura, S.-I.; Lehtiö, J.; Gabius, H.-J. Tumour suppressor p16(INK4a): Anoikis-favouring decrease in N/O-glycan/cell surface sialylation by down-regulation of enzymes in sialic acid biosynthesis in tandem in a pancreatic carcinoma model. FEBS J. 2012, 279, 4062-4080.
25. Liu, L.; Hirschberg, C.B. Developmental diseases caused by impaired nucleotide sugar transporters. Glycoconj. J. 2013, 30, 5-10.
26. Laine, R.A. The information-storing potential of the sugar code. In Glycosciences: Status and Perspectives; Gabius, H.-J., Gabius, S., Eds.; Chapman & Hall: London-Weinheim, UK/Germany, 1997; pp. 1-14.
27. Gabius, H.-J. Biological information transfer beyond the genetic code: The sugar code. Naturwissenschaften 2000, 87, 108-121.
28. Kopitz, J. Glycolipids. In The Sugar Code. Fundamentals of Glycosciences; Gabius, H.-J., Ed.; Wiley-VCH: Weinheim, Germany, 2009; pp. 177-198.
29. Unverzagt, C.; André, S.; Seifert, J.; Kojima, S.; Fink, C.; Srikrishna, G.; Freeze, H.; Kayser, K.; Gabius, H.-J. Structure-activity profiles of complex biantennary glycans with core fucosylation and with/without additional 2,3/2,6-sialylation: Synthesis of neoglycoproteins and their properties in lectin assays, cell binding, and organ uptake. J. Med. Chem. 2002, 45, 478-491.
30. André, S.; Unverzagt, C.; Kojima, S.; Frank, M.; Seifert, J.; Fink, C.; Kayser, K.; von der Lieth, C.-W.; Gabius, H.-J. Determination of modulation of ligand properties of synthetic complex-type biantennary N-glycans by introduction of bisecting GlcNAc in silico, in vitro and in vivo. Eur. J. Biochem. 2004, 271, 118-134.
31. André, S.; Kozár, T.; Schuberth, R.; Unverzagt, C.; Kojima, S.; Gabius, H.-J. Substitutions in the N-glycan core as regulators of biorecognition: The case of core-fucose and bisecting GlcNAc moieties. Biochemistry 2007, 46, 6984-6995.
32. André, S.; Kozár, T.; Kojima, S.; Unverzagt, C.; Gabius, H.-J. From structural to functional glycomics: Core substitutions as molecular switches for shape and lectin affinity of N-glycans. Biol. Chem. 2009, 390, 557-565.
33. Gabius, H.-J.; van de Wouwer, M.; André, S.; Villalobo, A. Down-regulation of the epidermal growth factor receptor by altering N-glycosylation: Emerging role of β1,4-galactosyltransferases. Anticancer Res. 2012, 32, 1565-1572.
34. Quiocho, F.A. Carbohydrate-binding proteins: Tertiary structures and protein-sugar interactions. Annu. Rev. Biochem. 1986, 55, 287-315.
35. Lis, H.; Sharon, N. Lectins: Carbohydrate-specific proteins that mediate cellular recognition. Chem. Rev. 1998, 98, 637-674.
36. Gabius, H.-J.; André, S.; Jiménez-Barbero, J.; Romero, A.; Solís, D. From lectin structure to functional glycomics: Principles of the sugar code. Trends Biochem. Sci. 2011, 36, 298-313.
37. Gabius, H.-J. The how and why of Ca2+ involvement in lectin activity. Trends Glycosci. Glycotechnol. 2011, 23, 168-177.
38. Sperandio, M. Selectins and glycosyltransferases in leukocyte rolling in vivo. FEBS J. 2006, 273, 4377-4389.
39. André, S.; Sanchez-Ruderisch, H.; Nakagawa, H.; Buchholz, M.; Kopitz, J.; Forberich, P.; Kemmner, W.; Böck, C.; Deguchi, K.; Detjen, K.M.; et al. Tumor suppressor p16INK4a: Modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells. FEBS J. 2007, 274, 3233-3256.
40. Wang, J.; Lu, Z.H.; Gabius, H.-J.; Rohowsky-Kochan, C.; Ledeen, R.W.; Wu, G. Cross-linking of GM1 ganglioside by galectin-1 mediates regulatory T cell activity involving TRPC5 channel activation: Possible role in suppressing experimental autoimmune encephalomyelitis. J. Immunol. 2009, 182, 4036-4045.
41. Wu, G.; Lu, Z.H.; Gabius, H.-J.; Ledeen, R.W.; Bleich, D. Ganglioside GM1 deficiency in effector T cells from NOD mice induces resistance to regulatory T cell suppression. Diabetes 2011, 60, 2341-2349.
42. Kopitz, J.; Bergmann, M.; Gabius, H.-J. How adhesion/growth-regulatory galectins-1 and -3 attain cell specificity: Case study defining their target on neuroblastoma cells (SK-N-MC) and marked affinity regulation by affecting microdomain organization of the membrane. IUBMB Life 2010, 62, 624-628.
43. Fischer, C.; Sanchez-Ruderisch, H.; Welzel, M.; Wiedenmann, B.; Sakai, T.; André, S.; Gabius, H.-J.; Khachigian, L.; Detjen, K.; Rosewicz, S. Galectin-1 interacts with the 5-1 fibronectin receptor to restrict carcinoma cell growth via induction of p21 and p27. J. Biol. Chem. 2005, 280, 37266-37277.
44. Gabius, H.-J. Animal and human lectins. In The Sugar Code. Fundamentals of Glycosciences; Gabius, H.-J., Ed.; Wiley-VCH: Weinheim, Germany, 2009; pp. 317-328.
45. Hudgin, R.L.; Pricer, W.E., Jr.; Ashwell, G.; Stockert, R.J.; Morell, A.G. The isolation and properties of a rabbit liver binding protein specific for asialoglycoproteins. J. Biol. Chem. 1974, 249, 5536-5543.
46. Lee, Y.C.; Townsend, R.R.; Hardy, M.R.; Lönngren, J.; Arnarp, J.; Haraldsson, M.; Lönn, H. Binding of synthetic oligosaccharides to the hepatic Gal/GalNAc lectin. J. Biol. Chem. 1983, 258, 199-202.
47. Rogers, J.C.; Kornfeld, S. Hepatic uptake of proteins coupled to fetuin glycopeptide. Biochem. Biophys. Res. Commun. 1971, 45, 622-629.
48. Lee, R.T.; Lin, P.; Lee, Y.C. New synthetic cluster ligands for galactose/N-acetylgalactosaminespecific lectin of mammalian liver. Biochemistry 1984, 23, 4255-4261.
49. Lee, R.T.; Lee, Y.C., Preparation of cluster glycosides of N-acetylgalactosamine that have subnanomolar binding constants towards the mammalian hepatic Gal/GalNAc-specific receptor. Glycoconj. J. 1987, 4, 317-328.
50. André, S.; Kojima, S.; Gundel, G.; Russwurm, R.; Schratt, X.; Unverzagt, C.; Gabius, H.-J. Branching mode in complex-type triantennary N-glycans as regulatory element of their ligand properties. Biochim. Biophys. Acta 2006, 1760, 768-782.
51. Lee, R.T.; Lee, Y.C. Enhanced biochemical affinities of multivalent neoglycoconjugates. In Neoglycoconjugates. Preparation and Applications; Lee, Y.C.; Lee, R.T., Eds.; Academic Press: San Diego, CA, USA, 1994; pp. 23-50.
52. Siebert, H.-C.; Adar, R.; Arango, R.; Burchert, M.; Kaltner, H.; Kayser, G.; Tajkhorshid, E.; von der Lieth, C.-W.; Kaptein, R.; Sharon, N.; et al. Involvement of laser photo CIDNP (chemically induced dynamic nuclear polarization)-reactive amino acid side chains in ligand binding by galactoside-specific lectins in solution. Eur. J. Biochem. 1997, 249, 27-38.
53. Göhler, A.; Büchner, C.; André, S.; Doose, S.; Kaltner, H.; Gabius, H.-J. Sensing ligand binding to a clinically relevant lectin by tryptophan fluorescence anisotropy. Analyst 2011, 136, 5270-5276.
54. Göhler, A.; Büchner, C.; Doose, S.; Kaltner, H.; Gabius, H.-J. Analysis of homodimeric avian and human galectins by two methods based on fluorescence spectroscopy: Different structural alterations upon oxidation and ligand binding. Biochimie 2012, 94, 2649-2655.
55. López-Lucendo, M.F.; Solís, D.; André, S.; Hirabayashi, J.; Kasai, K.-I.; Kaltner, H.; Gabius, H.-J.; Romero, A. Growth-regulatory human galectin-1: Crystallographic characterisation of the structural changes induced by single-site mutations and their impact on the thermodynamics of ligand binding. J. Mol. Biol. 2004, 343, 957-970.
56. Kasai, K.-I.; Hirabayashi, J. Galectins: A family of animal lectins that decipher glycocodes. J. Biochem. 1996, 119, 1-8.
57. Cooper, D.N.W. Galectinomics: Finding themes in complexity. Biochim. Biophys. Acta 2002, 1572, 209-231.
58. Kaltner, H.; Gabius, H.-J. A toolbox of lectins for translating the sugar code: the galectin network in phylogenesis and tumors. Histol. Histopathol. 2012, 27, 397-416.
59. Gupta, D.; Kaltner, H.; Dong, X.; Gabius, H.-J.; Brewer, C.F. Comparative cross-linking activities of lactose-specific plant and animal lectins and a natural lactose-binding immunoglobulin G fraction from human serum with asialofetuin. Glycobiology 1996, 6, 843-849.
60. Kopitz, J.; von Reitzenstein, C.; André, S.; Kaltner, H.; Uhl, J.; Ehemann, V.; Cantz, M.; Gabius, H.-J. Negative regulation of neuroblastoma cell growth by carbohydrate-dependent surface binding of galectin-1 and functional divergence from galectin-3. J. Biol. Chem. 2001, 276, 35917-35923.
61. Sanchez-Ruderisch, H.; Fischer, C.; Detjen, K.M.; Welzel, M.; Wimmel, A.; Manning, J.C.; André, S.; Gabius, H.-J. Tumor suppressor p16INK4a: Downregulation of galectin-3, an endogenous competitor of the pro-anoikis effector galectin-1, in a pancreatic carcinoma model. FEBS J. 2010, 277, 3552-3563.
62. Gabius, H.-J.; Brehler, R.; Schauer, A.; Cramer, F. Localization of endogenous lectins in normal human breast, benign breast lesions and mammary carcinomas. Virch. Arch. [Cell. Pathol.] 1986, 52, 107-115.
63. Kayser, K.; Höft, D.; Hufnagl, P.; Caselitz, J.; Zick, Y.; André, S.; Kaltner, H.; Gabius, H.-J. Combined analysis of tumor growth pattern and expression of endogenous lectins as a prognostic tool in primary testicular cancer and its lung metastases. Histol. Histopathol. 2003, 18, 771-779.
64. Saussez, S.; de Leval, L.; Decaestecker, C.; Sirtaine, N.; Cludts, S.; Duray, A.; Chevalier, D.; André, S.; Gabius, H.-J.; Remmelink, M.; Leroy, X. Galectin fingerprinting in Warthin's tumors: Lectin-based approach to trace its origin? Histol. Histopathol. 2010, 25, 541-550.
65. Remmelink, M.; de Leval, L.; Decaestecker, C.; Duray, A.; Crompot, E.; Sirtaine, N.; Andre, S.; Kaltner, H.; Leroy, X.; Gabius, H.J.; et al. Quantitative immunohistochemical fingerprinting of adhesion/growth-regulatory galectins in salivary gland tumours: Divergent profiles with diagnostic potential. Histopathology 2011, 58, 543-556.
66. André, S.; Jarikote, D.V.; Yan, D.; Vincenz, L.; Wang, G.N.; Kaltner, H.; Murphy, P.V.; Gabius, H.-J. Synthesis of bivalent lactosides and their activity as sensors for differences between lectins in inter- and intrafamily comparisons. Bioorg. Med. Chem. Lett. 2012, 22, 313-318.
67. Den, H.; Malinzak, D.A. Isolation and properties of -D-galactoside- specific lectin from chick embryo thigh muscle. J. Biol. Chem. 1977, 252, 5444-5448.
68. Beyer, E.C.; Zweig, S.E.; Barondes, S.H. Two lactose-binding lectins from chicken tissues. Purified lectin from intestine is different from those in liver and muscle. J. Biol. Chem. 1980, 255, 4236-4239.
69. Oda, Y.; Kasai, K.-I. Purification and characterization of -galactoside-binding lectin from chick embryonic skin. Biochim. Biophys. Acta 1983, 761, 237-245.
70. Kaltner, H.; Solís, D.; Kopitz, J.; Lensch, M.; Lohr, M.; Manning, J.C.; Mürnseer, M.; Schnölzer, M.; André, S.; Sáiz, J.L.; et al. Proto-type chicken galectins revisited: Characterization of a third protein with distinctive hydrodynamic behaviour and expression pattern in organs of adult animals. Biochem. J. 2008, 409, 591-599.
71. Kaltner, H.; Solís, D.; André, S.; Lensch, M.; Manning, J.C.; Mürnseer, M.; Saíz, J.L.; Gabius, H.-J. Unique chicken tandem-repeat-type galectin: Implications of alternative splicing and a distinct expression profile compared to those of the three proto-type proteins. Biochemistry 2009, 48, 4403-4416.
72. Kaltner, H.; Kübler, D.; López-Merino, L.; Lohr, M.; Manning, J.C.; Lensch, M.; Seidler, J.; Lehmann, W.D.; André, S.; Solís, D.; et al. Toward comprehensive analysis of the galectin network in chicken: Unique diversity of galectin-3 and comparison of its localization profile in organs of adult animals to the other four members of this lectin family. Anat. Rec. 2011, 294, 427-444.
73. Ledeen, R.W.; Wu, G.; André, S.; Bleich, D.; Huet, G.; Kaltner, H.; Kopitz, J.; Gabius, H.-J. Beyond glycoproteins as galectin counterreceptors: Tumor/effector T cell growth control via ganglioside GM1. Ann. NY Acad. Sci. 2012, 1253, 206-221.
74. Fulton, D.A.; Stoddart, J.F. Neoglycoconjugates based on cyclodextrins and calixarenes. Bioconjug. Chem. 2001, 12, 655-672.
75. Houseman, B.T.; Mrksich, M. Model systems for studying polyvalent carbohydrate binding interactions. Top. Curr. Chem. 2002, 218, 1-44.
76. Mellet, C.O.; Defaye, J.; Fernandez, J.M.G. Multivalent cyclooligosaccharides: Versatile carbohydrate clusters with dual role as molecular receptors and lectin ligands. Chem. Eur. J. 2002, 8, 1982-1990.
77. Furuike, T.; Aiba, S.; Nishimura, S.I. A highly practical synthesis of cyclodextrin-based glycoclusters having enhanced affinity with lectins. Tetrahedron 2000, 56, 9909-9915.
78. André, S.; Kaltner, H.; Furuike, T.; Nishimura, S.-I.; Gabius, H.-J. Persubstituted cyclodextrin-based glycoclusters as inhibitors of protein-carbohydrate recognition using purified plant and mammalian lectins and wild-type and lectin-gene-transfected tumor cells as targets. Bioconjug. Chem. 2004, 15, 87-98.
79. Ahmad, N.; Gabius, H.-J.; André, S.; Kaltner, H.; Sabesan, S.; Roy, R.; Liu, B.; Macaluso, F.; Brewer, C.F. Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes. J. Biol. Chem. 2004, 279, 10841-10847.
80. André, S.; Liu, B.; Gabius, H.-J.; Roy, R. First demonstration of differential inhibition of lectin binding by synthetic tri-and tetravalent glycoclusters from cross-coupling of rigidified 2-propynyl lactoside. Org. Biomol. Chem. 2003, 1, 3909-3916.
81. André, S.; Specker, D.; Bovin, N.V.; Lensch, M.; Kaltner, H.; Gabius, H.-J.; Wittmann, V. Carbamate-linked lactose: Design of clusters and evidence for selectivity to block binding of human lectins to (neo)glycoproteins with increasing degree of branching and to tumor cells. Bioconjug.e Chem. 2009, 20, 1716-1728.
82. Nelson, A.; Belitsky, J.M.; Vidal, S.; Joiner, C.S.; Baum, L.G.; Stoddart, J.F. A self-assembled multivalent pseudopolyrotaxane for binding galectin-1. J. Am. Chem. Soc. 2004, 126, 11914-11922.
83. Belitsky, J.M.; Nelson, A.; Hernandez, J.D.; Baum, L.G.; Stoddart, J.F. Multivalent interactions between lectins and supramolecular complexes: Galectin-1 and self-assembled pseudopolyrotaxanes. Chem. Biol. 2007, 14, 1140-1151.
84. Wittmann, V.; Seeberger, S. Combinatorial solid-phase synthesis of multivalent cyclic neoglycopeptides. Angew. Chem. Int. Ed. 2000, 39, 4348-4352.
85. Renaudet, O. Recent advances on cyclopeptide-based glycoclusters. Mini-Rev. Org. Chem. 2008, 5, 274-286.
86. André, S.; Renaudet, O.; Bossu, I.; Dumy, P.; Gabius, H.-J. Cyclic neoglycodecapeptides: how to increase their inhibitory activity and selectivity on lectin/toxin binding to a glycoprotein and cells. J. Pept. Sci. 2011, 17, 427-437.
87. Dam, T.K.; Gabius, H.-J.; André, S.; Kaltner, H.; Lensch, M.; Brewer, C.F. Galectins bind to the multivalent glycoprotein asialofetuin with enhanced affinities and a gradient of decreasing binding constants. Biochemistry 2005, 44, 12564-12571.
88. Kopitz, J.; Ballikaya, S.; André, S.; Gabius, H.-J. Ganglioside GM1/galectin-dependent growth regulation in human neuroblastoma cells: Special properties of bivalent galectin-4 and significance of linker length for ligand selection. Neurochem. Res. 2012, 37, 1267-1276.
89. André, S.; Sansone, F.; Kaltner, H.; Casnati, A.; Kopitz, J.; Gabius, H.-J.; Ungaro, R. Calix[n]arene-based glycoclusters: Bioactivity of thiourea-linked galactose/lactose moieties as inhibitors of binding of medically relevant lectins to a glycoprotein and cell-surface glycoconjugates and selectivity among human adhesion/growth-regulatory galectins. ChemBioChem 2008, 9, 1649-1661.
90. Cecioni, S.; Matthews, S.E.; Blanchard, H.; Praly, J.P.; Imberty, A.; Vidal, S. Synthesis of lactosylated glycoclusters and inhibition studies with plant and human lectins. Carbohydr. Res. 2012, 356, 132-141.
91. André, S.; Grandjean, C.; Gautier, F.M.; Bernardi, S.; Sansone, F.; Gabius, H.-J.; Ungaro, R. Combining carbohydrate substitutions at bioinspired positions with multivalent presentation towards optimising lectin inhibitors: Case study with calixarenes. Chem. Commun. (Camb) 2011, 47, 6126-6128.
92. Bukownik, R.R.; Wilcox, C.S. Synthetic receptors. 3,6-Anhydro-7- benzenesulfonamido-1,7- dideoxy-4,5-O-isopropylidene-D-altro-hept-1-ynitol: A useful component for the preparation of chiral water-soluble cyclophanes based on carbohydrate precursors. J. Org. Chem. 1988, 53, 463-467.
93. Jiménez-Barbero, J.; Junquera, E.; Martin-Pastor, M.; Sharma, S.; Vicent, C.; Penades, S. Molecular recognition of carbohydrates using a synthetic receptor. A model system to understand the stereoselectivity of a carbohydrate-carbohydrate interaction in water. J. Am. Chem. Soc. 1995, 117, 11198-11204.
94. Gulder, T.; Baran, P.S. Strained cyclophane natural products: Macrocyclization at its limits. Nat. Prod. Rep. 2012, 29, 899-934.
95. Velasco-Torrijos, T.; Murphy, P.V. Synthesis and conformational analysis of novel water soluble macrocycles incorporating carbohydrates, including a -cyclodextrin mimic. Tetrahedron- Asymmetr. 2005, 16, 261-272.
96. Murphy, P.V.; Müller-Bunz, H.; Velasco-Torrijos, T. The crystal structure of a cyclic glycolipid reveals a carbohydrate-carbohydrate interaction interface. Carbohydr. Res. 2005, 340, 1437-1440.
97. Murphy, P.V., Peptidomimetics, glycomimetics and scaffolds from carbohydrate building blocks. Eur. J. Org. Chem. 2007, 4177-4187.
98. Polakova, M.; Pitt, N.; Tosin, M.; Murphy, P.V. Glycosidation reactions of silyl ethers with conformationally inverted donors derived from glucuronic acid: Stereoselective synthesis of glycosides and 2-deoxyglycosides. Angew. Chem. Int. Ed. 2004, 43, 2518-2521.
99. Bradley, H.; Fitzpatrick, G.; Glass, W.K.; Kunz, H.; Murphy, P.V. Application of Ugi reactions in synthesis of divalent neoglycoconjugates: Evidence that the sugars are presented in restricted conformation. Org. Lett. 2001, 3, 2629-2632.
100. Ugi, I.; Werner, B.; Dömling, A., The chemistry of isocyanides, their multicomponent reactions and their libraries. Molecules 2003, 8, 53-66.
101. Leyden, R.; Velasco-Torrijos, T.; André, S.; Gouin, S.; Gabius, H.-J.; Murphy, P.V. Synthesis of bivalent lactosides based on terephthalamide, N,N'-diglucosylterephthalamide, and glycophane scaffolds and assessment of their inhibitory capacity on medically relevant lectins. J. Org. Chem. 2009, 74, 9010-9026.
102. Tornoe, C.W.; Christensen, C.; Meldal, M. Peptidotriazoles on solid phase: [1,2,3]-Triazoles by regiospecific copper(i)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. J. Org. Chem. 2002, 67, 3057-3064.
103. Trnka, T.M.; Grubbs, R.H. The development of L2X2Ru=CHR olefin metathesis catalysts: An organometallic success story. Acc. Chem. Res. 2001, 34, 18-29.
104. Jarikote, D.V.; Murphy, P.V. Metathesis and macrocycles with embedded carbohydrates. Eur. J. Org. Chem. 2010, 4959-4970.
105. Mohamadi, F.; Richards, N.G.J.; Guida, W.C.; Liskamp, R.; Lipton, M.; Caufield, C.; Chang, G.; Hendrickson, T.; Still, W.C. Macromodel: An integrated software system for modeling organic and bioorganic molecules using molecular mechanics. J. Comput. Chem. 1990, 11, 440-467.
106. André, S.; Velasco-Torrijos, T.; Leyden, R.; Gouin, S.; Tosin, M.; Murphy, P.V.; Gabius, H.-J. Phenylenediamine-based bivalent glycocyclophanes: Synthesis and analysis of the influence of scaffold rigidity and ligand spacing on lectin binding in cell systems with different glycomic profiles. Org. Biomol. Chem. 2009, 7, 4715-4725.
107. Wang, G.-N.; André, S.; Gabius, H.-J.; Murphy, P.V. Bi- to tetravalent glycoclusters: Synthesis, structure-activity profiles as lectin inhibitors and impact of combining both valency and headgroup tailoring on selectivity. Org. Biomol. Chem. 2012, 10, 6893-6907.
108. Ahmed, H.; Allen, H.J.; Sharma, A.; Matta, K.L. Human splenic galaptin: Carbohydrate-binding specificity and characterization of the combining site. Biochemistry 1990, 29, 5315-5319.
109. Lee, R.T.; Ichikawa, Y.; Allen, H.J.; Lee, Y.C. Binding characteristics of galactoside-binding lectin (galaptin) from human spleen. J. Biol. Chem. 1990, 265, 7864-7871.
110. André, S.; Giguère, D.; Dam, T.K.; Brewer, C.F.; Gabius, H.-J.; Roy, R. Synthesis and screening of a small glycomimetic library for inhibitory activity on medically relevant galactoside-specific lectins in assays of increasing biorelevance. New J. Chem. 2010, 34, 2229-2240.
111. Giguère, D.; André, S.; Bonin, M.A.; Bellefleur, M.A.; Provencal, A.; Cloutier, P.; Pucci, B.; Roy, R.; Gabius, H.-J.Inhibitory potential of chemical substitutions at bioinspired sites of -Dgalactopyranose on neoglycoprotein/cell surface binding of two classes of medically relevant lectins. Bioorg. Med. Chem. 2011, 19, 3280-3287.
112. Sparrow, C.; Leffler, H.; Barondes, S.H. Multiple soluble-galactoside- binding lectins from human lung. J. Biol. Chem. 1987, 262, 7383-7390.
113. Solís, D.; Romero, A.; Kaltner, H.; Gabius, H.-J.; Díaz-Mauriño, T. Different architecture of the combining sites of two chicken galectins revealed by chemical-mapping studies with synthetic ligand derivatives. J. Biol. Chem. 1996, 271, 12744-12748.
114. Ahmad, N.; Gabius, H.-J.; Kaltner, H.; André, S.; Kuwabara, I.; Liu, F.-T.; Oscarson, S.; Norberg, T.; Brewer, C.F. Thermodynamic binding studies of cell surface carbohydrate epitopes to galectins-1, -3 and -7. Evidence for differential binding specificities. Can. J. Chem. 2002, 80, 1096-1104.
115. Hirabayashi, J.; Hashidate, T.; Arata, Y.; Nishi, N.; Nakamura, T.; Hirashima, M.; Urashima, T.; Oka, T.; Futai, M.; Müller, W.E.G.; et al. Oligosaccharide specificity of galectins: A search by frontal affinity chromatography. Biochim. Biophys. Acta 2002, 1572, 232-254.
116. Stowell, S.R.; Arthur, C.M.; Slanina, K.A.; Horton, J.R.; Smith, D.F.; Cummings, R.D. Dimeric Galectin-8 induces phosphatidylserine exposure in leukocytes through polylactosamine recognition by the C-terminal domain. J. Biol. Chem. 2008, 283, 20547-20559.
117. Solís, D.; Maté, M.J.; Lohr, M.; Ribeiro, J.P.; López-Merino, L.; André, S.; Buzamet, E.; Cañada, F.J.; Kaltner, H.; Lensch, M.; et al. N-Domain of human adhesion/growth-regulatory galectin-9: Preference for distinct conformers and non-sialylated N-glycans and detection of ligand-induced structural changes in crystal and solution. Int. J. Biochem. Cell Biol. 2010, 42, 1019-1029.
118. Krzeminski, M.; Singh, T.; André, S.; Lensch, M.; Wu, A.M.; Bonvin, A.M.J.J.; Gabius, H.-J. Human galectin-3 (Mac-2 antigen): Defining molecular switches of affinity to natural glycoproteins, structural and dynamic aspects of glycan binding by flexible ligand docking and putative regulatory sequences in the proximal promoter region. Biochim. Biophys. Acta 2011, 1810, 150-161.
119. Martín-Santamaría, S.; André, S.; Buzamet, E.; Caraballo, R.; Fernández-Cureses, G.; Morando, M.; Ribeiro, J.P.; Ramírez-Gualito, K.; de Pascual-Teresa, B.; Cañada, F.J.; et al. Strategic combination of binding studies and NMR spectroscopy and detection of selectivity between a plant toxin and human lectins. Org. Biomol. Chem. 2011, 9, 5445-5455.
120. Miller, M.C.; Ribeiro, J.P.; Roldós, V.; Martín- Santamaría, S.; Cañada, F.J.; Nesmelova, I.V.; André, S.; Pang, M.; Klyosov, A.A.; Baum, L.G.; et al. Structural aspects of binding of -linked digalactosides to human galectin-1. Glycobiology 2011, 21, 1627-1641.
121. Vokhmyanina, O.A.; Rapoport, E.M.; André, S.; Severov, V.V.; Ryzhov, I.; Pazynina, G.V.; Korchagina, E.; Gabius, H.-J.; Bovin, N.V. Comparative study of the glycan specificities of cellbound human tandem-repeat-type galectins-4, -8 and -9. Glycobiology 2012, 22, 1207-1217.
122. Delacour, D.; Gouyer, V.; Zanetta, J.-P.; Drobecq, H.; Leteurtre, E.; Grard, G.; Moreau- Hannedouche, O.; Maes, E.; Pons, A.; André, S.; et al. Galectin-4 and sulfatides in apical membrane trafficking in enterocyte-like cells. J. Cell Biol. 2005, 169, 491-501.
123. Stechly, L.; Morelle, W.; Dessein, A.F.; André, S.; Grard, G.; Trinel, D.; Dejonghe, M.J.; Leteurtre, E.; Drobecq, H.; Trugnan, G.; et al. Galectin-4-regulated delivery of glycoproteins to the brush border membrane of enterocyte-like cells. Traffic 2009, 10, 438-450.
124. Wu, A.M.; Wu, J.H.; Liu, J.-H.; Singh, T.; André, S.; Kaltner, H.; Gabius, H.-J. Effects of polyvalency of glycotopes and natural modifications of human blood group ABH/Lewis sugars at the Gal1-terminated core saccharides on the binding of domain-I of recombinant tandemrepeat- type galectin-4 from rat gastrointestinal tract (G4-N). Biochimie 2004, 86, 317-326.
125. Oscarson, S. The chemist's way to synthesize glycosides. In The Sugar Code. Fundamentals of Glycosciences; Gabius, H.-J., Ed.; Wiley-VCH: Weinheim, Germany, 2009; pp. 31-51.
126. Chabre, Y.M.; Roy, R. The chemist's way to prepare multivalency. In The Sugar Code. Fundamentals of Glycosciences; Gabius, H.-J., Ed.; Wiley-VCH: Weinheim, Germany, 2009; pp. 53-70.
127. André, S.; Cejas Ortega, P.J.; Alamino Perez, M.; Roy, R.; Gabius, H.-J. Lactose-containing starburst dendrimers: Influence of dendrimer generation and binding-site orientation of receptors (plant/animal lectins and immunoglobulins) on binding properties. Glycobiology 1999, 9, 1253-1261.
128. Griegel, S.; Rajewsky, M.F.; Ciesiolka, T.; Gabius, H.J. Endogenous sugar receptor (lectin) profiles of human retinoblastoma and retinoblast cell lines analyzed by cytological markers, affinity chromatography and neoglycoprotein-targeted photolysis. Anticancer Res. 1989, 9, 723-730.
129. Bartoloni, M.; Dominguez, B.E.; Dragoni, E.; Richichi, B.; Fragai, M.; André, S.; Gabius, H.-J.; Arda, A.; Luchinat, C.; Jiménez-Barbero, J.; et al. Targeting matrix metalloproteinases: Design of a bifunctional inhibitor for presentation by tumour-associated galectins. Chem. Eur. J. 2013, 19, 1896-1902.
130. Habermann, F.A.; André, S.; Kaltner, H.; Kübler, D.; Sinowatz, F.; Gabius, H.-J. Galectins as tools for glycan mapping in histology: Comparison of their binding profiles to the bovine zona pellucida by confocal laser scanning microscopy. Histochem. Cell Biol. 2011, 135, 539-552.
131. Schlötzer-Schrehardt, U.; André, S.; Janko, C.; Kaltner, H.; Kopitz, J.; Gabius, H.-J.; Herrmann, M. Adhesion/growth-regulatory galectins in the human eye: Localization profiles and tissue reactivities as a standard to detect disease-associated alterations. Graefes Arch. Clin. Exp. Ophthalmol. 2012, 250, 1169-1180.
132. Smetana, K., Jr.; André, S.; Kaltner, H.; Kopitz, J.; Gabius, H.-J. Context-dependent multifunctionality of galectin-1: A challenge for defining the lectin as therapeutic target. Exp. Opin. Ther. Targ. 2013, 17, 379-392.
133. Rorive, S.; Belot, N.; Decaestecker, C.; Lefranc, F.; Gordower, L.; Micik, S.; Maurage, C.-A.; Kaltner, H.; Ruchoux, M.-M.; Danguy, A.; et al. Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma. Glia 2001, 33, 241-255.
134. Roda, O.; Ortiz-Zapater, E.; Martínez-Bosch, N.; Gutiérrez-Gallego, R.; Vila-Perelló, M.; Ampurdanés, C.; Gabius, H.-J.; André, S.; Andreu, D.; Real, F.X.; et al. Galectin-1 is a novel functional receptor for tissue plasminogen activator in pancreatic cancer. Gastroenterology 2009, 136, 1379-1390.
135. Gabius, H.-J.; Bodanowitz, S.; Schauer, A. Endogenous sugar-binding proteins in human breast tissue and benign and malignant breast lesions. Cancer 1988, 61, 1125-1131.
136. Gabius, H.-J.; Gabius, S.; Zemlyanukhina, T.V.; Bovin, N.V.; Brinck, U.; Danguy, A.; Joshi, S.S.; Kayser, K.; Schottelius, J.; Sinowatz, F.; et al. Reverse lectin histochemistry: Design and application of glycoligands for detection of cell and tissue lectins. Histol. Histopathol. 1993, 8, 369-383.
137. Kayser, K.; Bovin, N.V.; Korchagina, E.Y.; Zeilinger, C.; Zeng, F.-Y.; Gabius, H.-J. Correlation of expression of binding sites for synthetic blood group A-, B-, and H-trisaccharides and for sarcolectin with survival of patients with bronchial carcinoma. Eur. J. Cancer 1994, 30A, 653-657.
138. Gready, J.N.; Zelensky, A.N. Routes in lectin evolution: case study on the C-type lectin-like domains. In The Sugar Code. Fundamentals of Glycosciences; Gabius, H.-J., Ed.; Wiley-VCH: Weinheim, Germany, 2009; pp. 329-346.
139. André, S.; Kopitz, J.; Kaltner, H.; Villalobo, A.; Gabius, H.-J. Glycans as functional markers in malignancy? In The Sugar Code. Fundamentals of Glycosciences; Gabius, H.-J., Ed.; Wiley-VCH: Weinheim, Germany, 2009; pp. 419-432.
140. Schwartz-Albiez, R. Inflammation and glycosciences. In The Sugar Code. Fundamentals of Glycosciences; Gabius, H.-J., Ed.; Wiley-VCH: Weinheim, Germany, 2009; pp. 447-467.